DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 10589045)

Published in Cytometry on December 15, 1999

Authors

H L Flyger1, J K Larsen, H J Nielsen, I J Christensen

Author Affiliations

1: Department of Surgery, Hillerød Hospital, Hillerød, Denmark. flyger@dadlnet.dk

Articles by these authors

A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38

Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg (1997) 3.10

Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38

Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry (1983) 2.32

Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther (2012) 2.20

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol (1999) 1.86

Risk of recurrence 5 years or more after primary Lichtenstein mesh and sutured inguinal hernia repair. Br J Surg (2007) 1.82

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer (2005) 1.68

A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry (1990) 1.68

Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst (1999) 1.64

Mental aspects of temporal lobe epilepsy. Follow-up of 74 patients after resection of a temporal lobe. J Neurol Neurosurg Psychiatry (1979) 1.63

YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians (1999) 1.62

Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61

Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol (2000) 1.58

Serum YKL-40 and colorectal cancer. Br J Cancer (1999) 1.57

Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56

Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol (2000) 1.48

Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48

Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg (2000) 1.47

Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand (1999) 1.47

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer (2002) 1.47

The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol (1996) 1.45

Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg (2002) 1.41

Long-term storage of samples for flow cytometric DNA analysis. Cytometry (1983) 1.36

Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res (2000) 1.31

Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ (1999) 1.29

A precise and efficient stereological method for determining murine lung metastasis volumes. Am J Pathol (2001) 1.28

High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27

ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem (1997) 1.26

Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum (2001) 1.24

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24

Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer (2005) 1.24

Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci (2006) 1.22

Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg (2008) 1.18

Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis. Methods Cell Biol (1994) 1.17

DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta (1976) 1.17

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat (2000) 1.12

Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat (1997) 1.09

Flow cytometric discrimination of mitotic cells: resolution of M, as well as G1, S, and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde. Cytometry (1986) 1.09

Psychoses in drug-resistant temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1979) 1.08

Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08

The BPRS: psychometric developments. Psychopharmacol Bull (1988) 1.08

Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest (2002) 1.07

DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 1.07

Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res (1980) 1.05

Changing bone marrow micro-environment during development of acute myeloid leukaemia in rats. Br J Haematol (1998) 1.05

Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats. Cell Prolif (2000) 1.04

T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol (1993) 1.03

TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. Br J Cancer (2006) 1.02

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ (1998) 1.01

Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer (1986) 1.01

Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01. Scand J Immunol (1988) 1.00

A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet (1982) 1.00

Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves. J Orofac Pain (1995) 1.00

Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99

Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res (2001) 0.99

Soluble urokinase plasminogen activator receptor measurements: influence of sample handling. Int J Biol Markers (2002) 0.99

Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg (1997) 0.98

Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis (2011) 0.97

A method to study cell proliferation kinetics in human gastric mucosa. Gut (1975) 0.97

Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol (2012) 0.97

Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol Suppl (1994) 0.97

Postoperative morbidity among symptom-free alcohol misusers. Lancet (1992) 0.96

Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am J Hematol (2001) 0.95

[Side effects of perioperative blood transfusion--still a challenge]. Ugeskr Laeger (1993) 0.95

Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood (2000) 0.94

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res (1998) 0.94

Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol (2004) 0.94

Relationship between gastric acid secretion, histopathology, and cell proliferation kinetics in human gastric mucosa. Gastroenterology (1977) 0.93

In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res (1998) 0.93

Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis (2012) 0.93

Single cell DNA measurements in benign cutaneous lymphoid infiltrates and in positive patch tests. Br J Dermatol (1985) 0.93

Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response. Cancer (1988) 0.93

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin. Br J Cancer (1997) 0.92

Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood (1991) 0.91

Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J Immunol Methods (1994) 0.90

An integrated set of methods for routine flow cytometric DNA analysis. Methods Cell Biol (1990) 0.90

Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol (2011) 0.90

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer (1984) 0.90